219 results on '"Turnaturi, Rita"'
Search Results
2. Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body
3. Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid
4. Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia
5. Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation
6. From Plant to Chemistry: Sources of Antinociceptive Non-Opioid Active Principles for Medicinal Chemistry and Drug Design
7. Correction: CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications
8. Progress in the development of more effective and safer analgesics for pain management
9. Intercellular communication and ion channels in neuropathic pain chronicization
10. Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands
11. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application
12. From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design
13. Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines
14. Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review
15. Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review
16. Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain
17. New Insights into the Opioid Analgesic Profile of cis-(−)-N-Normetazocine-derived Ligands
18. Development of novel LP1-based analogues with enhanced delta opioid receptor profile
19. CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications.
20. Design, synthesis, in vitro evaluation, and molecular modeling studies of N ‐substituted benzomorphans, analogs of LP2 , as novel MOR ligands
21. Evaluation of N-substituent structural variations in opioid receptor profile of LP1
22. Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity
23. Multitarget opioid ligands in pain relief: New players in an old game
24. From Plant to Bench: Natural Products as Source for Analgesic Drug Development
25. CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications
26. Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands
27. Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain
28. Correction to “Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents”
29. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand
30. The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment
31. Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain
32. MOR/DOR Dual-Target Approach: 2S-LP2 Effects in Inflammatory and Neuropathic Pain
33. Hybrid MOR agonist/HDACi molecules as potential antinociceptive multi-target drugs: design, synthesis, and biological evaluation
34. Design, synthesis, and biological evaluation of new hybrid MOR agonist/HDACi compounds: an innovative approach for persistent pain management
35. Solid Lipid Nanoparticles as Carriers for the Synthetic Opioid LP2: Characterization and In Vitro Release
36. The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling
37. Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma
38. Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents
39. LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief
40. Design, Synthesis and biological evaluation of hybrid MOR agonist/ HDACi molecules as potential therapeutic agents for chronic pain treatment
41. Design, synthesis and biological evaluation of MOR agonist/HDACi hybrid compounds: a new potential therapeutic strategy for persistent pain management
42. Hybrid MOR agonist/HDACi molecules as potential new drugs for persistant pain management: design, synthesis and biological evaluation
43. The multitarget opioid ligand LP1ʼs effects in persistent pain and in primary cell neuronal cultures
44. Correction: CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications.
45. (2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist
46. From LP2 to 2S-LP2: discovery of a biased dual-target mu/delta opioid receptor agonist for pain management
47. Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation
48. Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist
49. Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists
50. Tuning Properties for Blood–Brain Barrier Permeation: A Statistics-Based Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.